|
1. Ramezani M, Nekozad N. [Comparison between the effectiveness of glucosamine sulfate and zintoma on clinical improvement of knee osteoarthritis]. EBNESINA. 2011; 14(3): 29-34. [Article in Persian] 2. Naito K, Watari T, Furuhat A, Yomogida S, Sakamoto K, Kurosawa H, et al. Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. Life Sciences. 2010 Mar; 86(13-14): 538-43. https://doi.org/10.1016/j.lfs.2010.02.015 3. Chubinskaya S, Hakimiyan A, Pacione C, Yanke A, Rappoport L, Aigner T, et al. Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads. Osteoarthritis Cartilage. 2007 Apr; 15(4): 421-30. DOI: 10.1016/j.joca.2006.10.004 4. Wei FY, Lee JK, Wei L, Qu F, Zhang JZ. Correlation of insulin-like growth factor 1 and osteoarthritic cartilage degradation: a spontaneous osteoarthritis in guinea-pig. Eur Rev Med Pharmacol Sci. 2017 Oct; 21(20): 4493-500. 5. Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010 Sep; 341: c4675. DOI: 10.1136/bmj.c4675 6. Zhang W, Moskowitz RW, Nuki G, Abamson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008; 16(2): 137-62. DOI: 10.1016/j.joca.2007.12.013 7. Xing C, Peng Y, Chang R, Yin Y, Xie Z. Effects of insulin- like growth factor-1 on okadaic acid-induced apoptosis in SH-SY5Y cells. Cell Biology International. 2005 Sep; 29(9): 803-8. DOI: 10.1016/j.cellbi.2005.04.012 8. Norman TM, Heesch KC, Brown WJ. Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee:a feasibility trial. Arthritis Res Ther. 2010; 12(1): R25. DOI: 10.1186/ar2932 9. Escribano O, Guillen C, Nevado C, Gomez-Hernandez A, Kahn CR, Benito M. Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor a isoform. Diabetes. 2009 Apr; 58(4): 820-28. DOI: 10.2337/db08-0551 10. Ng CT, Tan MP. Osteoarthritis and falls in the older person. Age Ageing. 2013 Sep; 42(5): 561-66. DOI: 10.1093/ageing/aft070 11. Galois L, Etienne S, Grossin L, Watrin-Pinzano A, Cournil-Henrionnet C, Loeuille D, et al. Dose–response relationship for exercise on severity of experimental osteoarthritis in rats: a pilot study. Osteoarthritis Cartilage. 2004 Oct; 12(10): 779-86. DOI: 10.1016/j.joca.2004.06.008 12. Golightly YM, Allen KD, Caine DJ. A comprehensive review of the effectiveness of different exercise programs for patients with osteoarthritis. Phys Sportsmed. 2012 Nov; 40(4): 52-65. DOI: 10.3810/psm.2012.11.1988 13. Cifuentes DJ, Rocha LG, Silva LA, Brito AC, Rueff-Barroso LC, Pinho RA. Decrease in oxidative stress and histological changes induced by physical exercise calibrated in rats with osteoarthritis induced by monosodium iodoacetate. Osteoarthritis Cartilage. 2010 Aug; 18(8): 1088-95. DOI: 10.1016/j.joca.2010.04.004 14. Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin Orthop Relat Res. 2011 Oct; 469(10): 2706-15. DOI: 10.1007/s11999-011-1857-3 15. Tavera C, Abribat T, Reboul P, Dore S, Brazeau P, Pelletier JP, et al. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis Cartilage 1996; 4(4): 263-74. https://doi.org/10.1016/S1063-4584(05)80104-9 16. Kalamegam G, Memic A, Budd E, Abbas M, Mobasheri A. A Comprehensive Review of Stem Cells for Cartilage Regeneration in Osteoarthritis. Adv Exp Med Biol. 2018; 1089: 23-36. DOI: 10.1007/5584_2018_205 17. Baxter RC. IGF binding protein-3 and the acid-labile subunit: formation of the ternary complex in vitro and in vivo. Adv Exp Med Biol. 1993; 343: 237-44. DOI: 10.1007/978-1-4615-2988-0_23 18. Blagojevic M, Jinks C, Jeffery A, Jordan KP. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2010 Jan; 18(1): 24-33. DOI: 10.1016/j.joca.2009.08.010 19. Eriksen P, Bartels EM, Altman RD, Bliddal H, Juhl C, Christensen R. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken). 2014 Dec; 66(12): 1844-55. DOI: 10.1002/acr.22376 20. Ezadpanah A, Moazami M, Khoshraftar Yazdi N. [Effect of a period of therapeutic exercise and detraining after that on balance in the women with knee osteoarthritis]. J Mod Rehabil. 2016; 9(S1): 101-9. [Article in Persian] 21. Kucharz EJ, Kovalenko V, Szanto S, Bruyere O, Cooper C, Reginster JY. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin. 2016 Jun; 32(6): 997-1004. DOI: 10.1185/03007995.2016.1154521 22. Zhao XX, Bi Y, Yin XY, Min R. Suppression of collagen- induced arthritis by lipopolysaccharide in DBA/1 mice. Eur Rev Med Pharmacol Sci. 2016; 20(3): 441-46. 23. Messier SP, Mihalko S, Loeser RF, Legault C, Jolla J, Pfruender J, et al. Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study. Osteoarthritis Cartilage. 2007; 15(11): 1256-66. https://doi.org/10.1016/j.joca.2007.04.016 24. Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, et al. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride. Osteoarthritis Cartilage. 2008 Sep; 16(9): 973-79. 25. Vasara AI , Konttinen YT , Peterson L, Lindahl A, Kiviranta I. Persisting high levels of synovial fluid markers after cartilage repair: a pilot study. Clin Orthop Relat Res. 2009 Jan; 467(1): 267-72. DOI: 10.1007/s11999-008-0434-x 26. Elford PR, Lamberts SW. Contrasting modulation by transforming growth factor-beta-1 of insulin-like growth factor-I production in osteoblasts and chondrocytes. Endocrinology. 1990; 127(4): 1635-39. https://doi.org/10.1210/endo-127-4-1635 27. Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther. 2006; 8: R177. https://doi.org/10.1186/ar2087 28. Roddy E, Zhang W, Doherty M, Arden NK, Barlow J, Birrel F, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee—the MOVE consensus. Rheumatology. 2005; 44(1): 67-73. https://doi.org/10.1093/rheumatology/keh399 29. Gallagher B, Tjoumakaris FP, Harwood MI, Good RP, Ciccotti MG, Freedman KB. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med. 2015 Mar; 43(3): 734-44. DOI: 10.1177/0363546514533777 30. Tesch GH, Handley CJ, Cornell HJ, Herington AC. Effects of free and bound insulin-like growth factors on proteoglycan metabolism in articular cartilage explants. J Orthop Res. 1992 Jan; 10(1): 14-22. DOI: 10.1002/jor.1100100103 31. Molloy IB, Martin BI, Moschetti WE, Jevsevar DS. Effects of the length of stay on the cost of total knee and total hip arthroplasty from 2002 to 2013. J Bone Joint Surg Am. 2017 Mar; 99(5): 402-7. DOI: 10.2106/JBJS.16.00019 32. Pinho RA, Andrades ME, Oliveira MR, Pirola AC, Zago MS, Silveira PCL, et al.; Imbalance in SOD/CAT activities in rat skeletal muscles submitted to treadmill training exercise. Cell Biol Int. 2006 Oct; 30(10): 848-53. DOI: 10.1016/j.cellbi.2006.03.011 33. Louboutin H, Debarge R, Richou J, Si Selmi TA, Donell ST, Neyret P, et al. Osteoarthritis in patients with anterior cruciate ligament rupture: A review of risk factors. Knee. 2009 Aug; 16(4): 239-44. DOI: 10.1016/j.knee.2008.11.004 34. Xia M, Li H, Wang JJ, Zeng HJ, Wang SH. MiR-99a suppress proliferation, migration and invasion through regulating insulin-like growth factor 1 receptor in breast cancer. Eur Rev Med Pharmacol Sci. 2016; 20: 1755-63.
|
